Medion Grifols Diagnostics Ag

FDA Filings

This page includes the latest FDA filings for Medion Grifols Diagnostics Ag. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Registration(s)
Registration Number3002806769
FEI Number3002806769
NameMEDION GRIFOLS DIAGNOSTICS AG
Owner & OperatorMEDION GRIFOLS DIAGNOSTICS AG
Contact AddressAvda. de la Generalitat, 152
Sant Cugat del Valles ES-B Barcelona 08174 ES
Official Correspondent
  • JOAQUIN - ALBERTO TAMPARILLAS
  • 34-67-0924632-x
US Agent
Registration Status1
Initial ImporterN
Registration Expiration2020-04-25
Registration AddressBONNSTRASSE 9
DUEDINGEN Fribourg, CH-3186 CH
Establishment Type
  • Manufacture Medical Device
  • Manufacture Medical Device for Another Party (Contract Manufacturer)



FDA Filings

Device
Company
DeviceDate
Medion Grifols Diagnostics AG
Data-Cyte Plus 3% 2132312024-04-18
Medion Grifols Diagnostics AG
Search-Cyte Pool 0.8% 2132892024-04-17
Medion Grifols Diagnostics AG
DG Gel Essential Control 2132882019-05-01
MEDION GRIFOLS DIAGNOSTICS AG
DG Gel Essential Control2019-04-11
Medion Grifols Diagnostics AG
Quality Control Kits For Blood Banking Reagents2019-01-17
Medion Grifols Diagnostics AG
DG Gel Extended Control 2132852018-03-29
Medion Grifols Diagnostics AG
Coombs Control Cells 2136302018-03-29
Medion Grifols Diagnostics AG
BBQA II 2136422018-03-29
Medion Grifols Diagnostics AG
Search-Cyte Pool 0.8% 2136632018-03-29
Medion Grifols Diagnostics AG
Search-Cyte TCS 0.8% 2136552018-03-29
Medion Grifols Diagnostics AG
Search-Cyte Plus 0.8% 2136562018-03-29
Medion Grifols Diagnostics AG
Search-Cyte I+II 0.8% 2136572018-03-29
Medion Grifols Diagnostics AG
Search-Cyte TCS 3% 2136312018-03-29
Medion Grifols Diagnostics AG
Search-Cyte Plus 3% 2136392018-03-29
Medion Grifols Diagnostics AG
Search-Cyte I+II 3% 2136382018-03-29
Medion Grifols Diagnostics AG
Reverse-Cyte 0.8% (A1, A2, B) 2136622018-03-29
Medion Grifols Diagnostics AG
Reverse-Cyte 0.8% (A1, B) 2136602018-03-29
Medion Grifols Diagnostics AG
Reverse-Cyte 3% (A1, A2, B) 2136322018-03-29
Medion Grifols Diagnostics AG
Reverse-Cyte 3% (A1, B) 2136352018-03-29
Medion Grifols Diagnostics AG
Data-Cyte Plus 0.8% 2136542018-03-29
Medion Grifols Diagnostics AG
Data-Cyte Plus 3% 2133922018-03-29
MEDION GRIFOLS DIAGNOSTICS AG
DG Gel Extended Control2017-04-11
Medion Grifols Diagnostics AG
Quality Control Kits For Blood Banking Reagents2014-04-11
MEDION GRIFOLS DIAGNOSTICS AG
Reagent Red Blood Cells2009-03-17
MEDION GRIFOLS DIAGNOSTICS AG
Coombs Control Cells2009-03-17
MEDION GRIFOLS DIAGNOSTICS AG
BBQA II2009-02-12
MEDION GRIFOLS DIAGNOSTICS AG
Sickle Cell2009-02-12
MEDION GRIFOLS DIAGNOSTICS AG
Sickle Trol2009-02-12

Related Finance Registrations

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.